logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Z

Zezhou Wang

fudan university
H指数:20
被引数:1,932

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bevacizumab plus nab-paclitaxel and platinum as second-line therapy for driver-gene-negative non-squamous non-small cell lung cancer after immunochemotherapy: A prospective single-arm single-centre study

贝伐珠单抗联合nab-紫杉醇和铂类作为免疫化疗后驱动基因阴性非鳞非小细胞肺癌的二线治疗：一项前瞻性单臂单中心研究

Clinical and Translational Medicine
IF6.8
2026-09-110
OA
Ying Lin; Yunbo Yu; Zhihuang Hu; Chenchen Wei; Zezhou Wang; Yao Zhang; Zhenhua Wu; Bo Yu; Xinmin Zhao; Hui Yu; Xianghua Wu; Huijie Wang; Jialei Wang
Lenalidomide combined with R-CHOP (R2-CHOP) in the treatment of newly diagnosed double-expressor diffuse large B-cell lymphoma: a prospective phase II clinical trial

来那度胺联合R-CHOP（R2-CHOP）治疗新诊断的双表达型弥漫大B细胞淋巴瘤：一项前瞻性II期临床试验

BLOOD CANCER JOURNAL
IF11.6
2025-02-250
OA
Liu, Yizhen; Zhang, Qunling; Lv, Fangfang; Liu, Xiaojian; Ji, Dongmei; Xia, Zuguang; Jin, Jia; Tao, Rong; Zhang, Wenhao; Li, Xiaoqiu; Zhang, Shengjian; Wang, Zezhou; Wang, Jiachen; Hong, Xiaonan; Cao, Junning
Dose escalation based on 18F-FDG PET/CT response in definitive chemoradiotherapy of locally advanced esophageal squamous cell carcinoma: a phase III, open-label, randomized, controlled trial (ESO-Shanghai 12)
RADIATION ONCOLOGY
IF3.2
2022-07-297
OAAI
Zhu, Hongcheng; Liu, Qiufang; Xu, Hao; Mo, Miao; Wang, Zezhou; Lu, Kui; Zhou, Jialiang; Chen, Junqiang; Zheng, Xiangpeng; Ye, Jinjun; Ge, Xiaolin; Luo, Honglei; Liu, Qi; Deng, Jiaying; Ai, Dashan; Hao, Shengnan; Zhang, Junhua; Tseng, I. Hsuan; Song, Shaoli; Chen, Yun; Zhao, Kuaile

研究方向

暂未获取到该数据
Y
Yong Cai
H 指数:37论文数:268被引数:5,117
H
Huwen Wang
H 指数:16论文数:53被引数:1,370
X
Xueqin Jiang
H 指数:10论文数:27被引数:324
L
Lhakpa Tsamlag
H 指数:12论文数:30被引数:1,069
M
Mengyun Luo
H 指数:16论文数:43被引数:1,409
G
Gang Xu
H 指数:39论文数:252被引数:4,765
Y
Yinqiao Dong
H 指数:13论文数:23被引数:1,665
S
Shawn S.‐C. Li
H 指数:44论文数:132被引数:6,764
M
Miao Mo
H 指数:31论文数:130被引数:3,373
王
王颖
H 指数:105论文数:1,508被引数:5.6万